• 利来w66(中国NO.1)集团有限公司利来w66

    Providing Healthcare for Everyone Everywhere

    Jointown Pharmaceutical Group Co., Ltd.

    Strive to build up the most professional comprehensive health service platform in China

    More
    billion RMB
    Operating Income in 2023
    billion RMB
    Net Income Attributable (Excl. Excep) in 2023
    billion RMB
    Net Cash Flow in 2023
    billion RMB
    Total Assets ending Sep. 30, 2024
    people
    Employees
    th
    Chinese Private Enterprise
    th
    Chinese Private Enterprise in Service Industry
    Sino-Securities Index ESG Ratings
    Digital Pharmaceutical Distribution and Supply Chain Business
    General Agency Brand Promotion Business
    Pharmaceutical Industrial Self-production and OEM Business
    Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
    Medical Health and Technology Value-added Services
    Digital Logistics Technology and Supply Chain Solutions
    Our Businesses

    Digital Pharmaceutical Distribution and Supply Chain Business

    More
    Jointown is committed to providing upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
    billion RMB
    Sales Revenue in the first 3 quarters of 2024
    billion RMB
    Gross Profit in the first 3 quarters of 2024
    +
    Youngjoin Active Users
    News Center

    Company Dynamics And Industry Information

    More
    Corporate News
    Improved operating performance quarter by quarter! Jointown's Q3 performance presentation held successfully
    In the first three quarters of the year, Jointown's operating income, net profit attributable to the parent company, and net profit attributable to the parent company after deducting non-recurring profit and loss reached RMB 113.429 billion, RMB 1.696 billion and RMB 1.630 billion, respectively.
    2024-11-01
    More
    Corporate News
    Jointown completed the respond to Feedback on Jointown REIT, stepping closer to Listing
    According to the disclosure of Shanghai Stock Exchange, on December 9, 2024, respond has been completed to the feedback on China Universal Jointown Pharmaceutical Warehousing and Logistics Closed-end REIT ("Jointown REIT"). This marks that Jointown REIT, as the first public REIT of the pharmaceutical logistics and warehousing facility in China, has taken one step closer to the final listing.
    2024-12-10
    More
    Corporate News
    Delegation from the Ministry of Health, the Kingdom of Saudi Arabia, Visited JOIN Digital Health Industry Park
    On the afternoon of December 5, 2024, a delegation from the Ministry of Health, the Kingdom of Saudi Arabia (hereinafter referred to as Saudi delegation), visited JOIN Digital Health Industry Park (referred to as JDHIpark), and received warm reception from Mr. Liu Zhaonian, Jointown’s Vice Chairman, Mr. Lin Xinyang, the Shareholder Representative Supervisor, and Ms. Deng Huiyan, the General Manager of JDHIpark.
    2024-12-06
    More
    Corporate News
    Jointown was awarded the "2023 Golden Bull Award for Most Valuable Investment"
    On 24 October, the 26th Golden Bull Award Ceremony for Listed Companies hosted by the China Securities Journal was held in Nantong, Jiangsu. Jointown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jointown" or the "Company") was awarded the "2023 Golden Bull Award for Most Valuable Investment". Liu Zhifeng, Deputy General Manager and Board Secretary of Jointown, was invited to attend the ceremony and accepted the award on stage.
    2024-10-24
    More
    Investor Relations

    Stock Information

    More
    Jointown Pharmaceutical Group Co., Ltd. 600998.SH
    4.82
    -0.01 -0.21%
    2025-01-10 15:05:00
    Open 4.85
    Previous Close 4.83
    High 4.85
    Low 4.77
    Volume 17,760,888
    Turnover 85,566,160RMB
    Announcement
    Q & A
    ESG
    Green development and technological empowerment create a sustainable future
    Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
    More

    Jointown Service Platforms

    Providing Healthcare for Everyone Everywhere

    Jointown Pharmaceutical Group Co., Ltd.

    Strive to build up the most professional comprehensive health service platform in China

    billion RMB
    Operating Income in 2023
    billion RMB
    Net Income Attributable (Excl. Excep) in 2023
    billion RMB
    Net Cash Flow in 2023
    billion RMB
    Total Assets ending Sep. 30, 2024
    people
    Employees
    th
    Chinese Private Enterprise
    th
    Chinese Private Enterprise in Service Industry
    Sino-Securities Index ESG Ratings
    More

    Our Businesses

    Digital Pharmaceutical Distribution and Supply Chain Business
    Jointown is committed to providing upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
    billion RMB
    Sales Revenue in the first 3 quarters of 2024
    billion RMB
    Gross Profit in the first 3 quarters of 2024
    +
    Youngjoin Active Users
    More
    General Agency Brand Promotion Business
    With its General Agency Brand Promotion (CSO) business moving into the fast lane, the Company continues to build the "second curve" for profit growth, and upgrades the brand of "ALL WAYS ENGINE".
    billion RMB
    Sales Revenue in the first 3 quarters of 2024
    Product Specifications of Drugs
    Product Specifications of Medical Devices
    More
    Pharmaceutical Industrial Self-production and OEM Business
    Based on the existing varieties, brands, channels and marketing advantages, Jointown has conducted targeted development of self-operated industrial products and OEM business by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform. The business enjoys cluster development with respect to self-owned varieties.
    billion RMB
    Sales Revenue in the first 3 quarters of 2024
    +
    Varieties of Drug Production
    OEM Product Specifications of Drugs
    More
    Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
    New retail and Ten-Thousand Store Alliance Plan business is an integral part of Jointown's "Three News and Two Transformations" strategic transformation, and the core of new retail strategy. Jointown makes full use of the established supply chain advantages to empower the retailing business, reach C-end users and expand the business through the "Ten-Thousand Store Alliance Plan", "integration of wholesale and retail" and the combination of online and offline channels.
    billion RMB
    Sales Revenue in the first 3 quarters of 2024
    Direct-Sale and Franchised Pharmacies
    O2O Retail Stores
    More
    Medical Health and Technology Value-added Services
    Jointown continues to carry out independent development and provides customers with information technology-driven value-added services; it also advances the development of medical diagnosis services, enhances public health service capabilities, and extends the business to medical services, health management, medical technology and other comprehensive health fields, to create a comprehensive health service platform.
    million RMB
    Sales Revenue in the first 3 quarters of 2024
    Patent Rights of Technical Information
    Software Copyright
    More
    Digital Logistics Technology and Supply Chain Solutions
    Relying on Jointown Cloud Warehouse, Jointown expands the third-party/fourth-party business and cold chain business, providing technology output and supply chain solutions.
    million RMB
    Sales Revenue in the first 3 quarters of 2024
    million m²
    GSP Warehouse
    Intelligent Logistics Patent
    More

    Company Dynamics And Industry Information

    More
    Corporate News
    Improved operating performance quarter by quarter! Jointown's Q3 performance presentation held successfully
    In the first three quarters of the year, Jointown's operating income, net profit attributable to the parent company, and net profit attributable to the parent company after deducting non-recurring profit and loss reached RMB 113.429 billion, RMB 1.696 billion and RMB 1.630 billion, respectively.
    2024-11-01
    Corporate News
    Jointown completed the respond to Feedback on Jointown REIT, stepping closer to Listing
    According to the disclosure of Shanghai Stock Exchange, on December 9, 2024, respond has been completed to the feedback on China Universal Jointown Pharmaceutical Warehousing and Logistics Closed-end REIT ("Jointown REIT"). This marks that Jointown REIT, as the first public REIT of the pharmaceutical logistics and warehousing facility in China, has taken one step closer to the final listing.
    2024-12-10
    Corporate News
    Delegation from the Ministry of Health, the Kingdom of Saudi Arabia, Visited JOIN Digital Health Industry Park
    On the afternoon of December 5, 2024, a delegation from the Ministry of Health, the Kingdom of Saudi Arabia (hereinafter referred to as Saudi delegation), visited JOIN Digital Health Industry Park (referred to as JDHIpark), and received warm reception from Mr. Liu Zhaonian, Jointown’s Vice Chairman, Mr. Lin Xinyang, the Shareholder Representative Supervisor, and Ms. Deng Huiyan, the General Manager of JDHIpark.
    2024-12-06
    Corporate News
    Jointown was awarded the "2023 Golden Bull Award for Most Valuable Investment"
    On 24 October, the 26th Golden Bull Award Ceremony for Listed Companies hosted by the China Securities Journal was held in Nantong, Jiangsu. Jointown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jointown" or the "Company") was awarded the "2023 Golden Bull Award for Most Valuable Investment". Liu Zhifeng, Deputy General Manager and Board Secretary of Jointown, was invited to attend the ceremony and accepted the award on stage.
    2024-10-24

    Stock Information

    More
    Jointown Pharmaceutical Group Co., Ltd.
    600998.SH
    4.82
    Open 4.85
    Previous Close 4.83
    Volume 17,760,888
    2025-01-10 15:05:00
    -0.01 -0.21%
    High 4.85
    Low 4.77
    Turnover 85,566,160RMB
    Announcement
    Q & A
    Green development and technological empowerment create a sustainable future
    Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
    More

    Jointown Service Platforms

    利来w66